(Press-News.org) The first published evidence from humans that semaglutide specifically reduces the symptoms of Alcohol Use Disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent collaboration between clinicians and scientists at the University of Oklahoma School of Community Medicine and Oklahoma State University Center for Health Sciences. The paper outlines the outcomes of six patients who received semaglutide during treatment for weight loss, demonstrating a significant and noteworthy decrease in their Alcohol Use Disorders Identification Test (AUDIT) scores.
The paper is titled "Significant Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide Therapy for Weight Loss: A Case Series." This collaboration has the potential to impact the lives of individuals struggling with Alcohol Use Disorder.
Semaglutide has made headlines recently as an FDA-approved drug for the treatment of diabetes under the name Ozempic, and weight loss under the name Wegovy. Recently, attention has turned to the possibility that semaglutide may have broader applications, including its potential impact on addictive behaviors such as reducing drug craving and alcohol consumption. Pre-clinical research in rodents and monkeys has demonstrated that semaglutide is associated with marked decreases in drug and alcohol consumption, and many patients taking the drug for diabetes and weight loss report significant reductions in the urge to drink alcohol.
"This research marks a significant step forward in our understanding of the potential therapeutic applications of semaglutide in the field of addiction medicine," said the lead author, Dr. Jesse Richards, director of Obesity Medicine and assistant professor of Medicine at OU-TU School of Community Medicine.
Dr. Kyle Simmons, the paper’s senior author and professor of Pharmacology & Physiology at OSU-Center for Health Sciences noted that this case series evidence paves the way for gold-standard placebo-controlled clinical trials such as the one he is currently conducting in Tulsa at the OSU Hardesty Center for Clinical Research and Neuroscience.
Called STAR (Semaglutide Therapy for Alcohol Reduction), the clinical trial is funded by the Hardesty Family Foundation and OSU-CHS. A sister study is also currently underway in Baltimore funded by the National Institute on Drug Abuse (NIDA).
“This is an example of what can happen when our two R-1 research institutions in Oklahoma collaborate,” said Simmons. “With the publication of this case series in the Journal of Clinical Psychiatry, the stage is set for future clinical trials, such as the STAR studies, which can definitively tell us whether semaglutide is safe and effective for treatment of alcohol use disorder.”
The researchers emphasized the need for further investigation through larger, controlled studies to validate and expand upon these initial findings. Until the results of future placebo-controlled clinical trials are available, the authors believe that healthcare providers should point patients toward established behavioral treatments and medications that have been validated by the FDA for alcohol use disorder.
Key Takeaways from the Research:
Semaglutide Treatment and Alcohol Use Disorder: The study reveals a marked reduction in Alcohol Use Disorder Identification Test (AUDIT) scores in all six patients who received semaglutide treatment in the course of pharmacotherapy for weight loss. The results suggest a potential role for this medication in the management of Alcohol Use Disorder.
Implications for Future Research: The findings open new avenues for future research into the use of glucagon-like peptide-1 medications, such as semaglutide, in the treatment of addictive behaviors.
Collaborative Research Model: This collaboration between The University of Oklahoma School of Community Medicine and Oklahoma State University Center for Health Sciences is an example of the potential when clinicians and scientists collaborate to explore innovative solutions to complex health care challenges.
END
The University of Oklahoma and Oklahoma State University collaboration finds semaglutide treatment is associated with remarkable reductions in Alcohol Use Disorder symptoms
2023-11-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Survey finds patients’ coping styles changed during COVID-19 and that stable coping styles can reduce anxiety and depression
2023-11-27
Researchers assessed Veterans Affairs participants’ patterns of coping strategies, as well as the stability and change in strategies, at three timepoints (December 2020-March 2021) when COVID-19 vaccines became widely available. Two thousand and eighty-five participants completed surveys at any time point during the specified time frame and 930 participants completed all three surveys. Researchers identified three distinct coping styles: Adaptive, Distressed, and Disengaged. They then assessed stability and change ...
Knowledge translation materials can promote discussions between Asian men with diabetes and their physicians about erectile dysfunction
2023-11-27
Researchers studied communication about erectile dysfunction (ED) between doctors and 120 Asian male patients with diabetes in a primary care clinic in Kedah, Malaysia. At the outset of the study, all participating physicians received a brief introduction to the fundamentals of ED treatment. Prior to a regular consultation, 60 men (the intervention group) were given a simple prompt sheet on which they could indicate whether they wanted to discuss, or were already discussing, ED with their doctor; physicians in the intervention group were provided with a knowledge translation flipchart developed by the researchers to ...
An AI-aided stethoscope can improve home monitoring of asthma in very young children
2023-11-27
Adults and older children with asthma can take objective measures of symptoms such as peak expiratory flow (PEF), the volume of airflow in one forced exhalation, at home. This provides a more complete picture of their disease and helps them detect asthma exacerbations or negative changes to their condition at the onset. However, a 2022 report by the Global Initiative for Asthma (GINA) identifies continuous respiratory sounds such as wheezes, rhonchi, as the best indicators of asthma exacerbation, especially in children under 5 years of age. Assessment of these symptoms, still primarily done by doctors using ...
Practice interventions to enhance integrated behavioral health care may have minimal effect on patient outcomes
2023-11-27
Researchers from around the United States collaborated on a clinical trial to test the effectiveness of a practice intervention for improving outcomes for patients with both physical and mental health problems by enhancing integrated behavioral health (IBH) activities. The research team recruited 42 primary care practice sites in 13 states, including internal medicine, family medicine, small and large groups, for-profit, academic, and safety-net clinics. Each site had a co-located behavioral health provider (a psychologist, social worker, or licensed counselor ...
November/December Annals of Family Medicine 2023 Tip Sheet
2023-11-27
International Group of Research Experts Establish Checklist Detailing Key Consensus Reporting Items for Primary Care Studies
In an effort to fill the need for primary care–focused guidelines, an international group of top researchers has developed the Consensus Reporting Items for Studies in Primary Care (CRISP) Checklist, which outlines 24 items that describe the research team, patients, study participants, health conditions, clinical encounters, care teams, interventions, study measures, settings of care, and implementation of ...
Unfiltered traffic-related air associated with immediate, significant blood pressure increase
2023-11-27
Embargoed for release until 5:00 p.m. ET on Monday 27 November 2023
Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Unfiltered ...
Practice facilitation programs can help primary care clinics adopt best practices for providing COVID-19 vaccinations
2023-11-27
In Ontario, Canada, most COVID-19 vaccinations were administered by public health organizations and pharmacies rather than by family physicians. Researchers devised a practice facilitation intervention program to help family physicians proactively engage with their patients who were not yet vaccinated for COVID‐19.
Six trained practice facilitators helped 90 family physicians identify unvaccinated patients and offered resources to address COVID‐19 vaccine hesitancy, scripts and email templates for patient outreach, and connections to trained medical student volunteers to work as physician‐delegates by conducting patient telephone outreach and motivational interviewing. ...
Breathing highway air increases blood pressure, UW research finds
2023-11-27
For more than a century, American cities have been sliced and diced by high-traffic roadways. Interstate highways and wide arterials are now a defining feature of most metropolitan areas, their constant flow of cars spewing pollution into nearby neighborhoods.
Researchers have only just begun to understand the health risks posed by all that pollution. Long-term exposure to traffic-related air pollution — a complex mixture of exhaust from tailpipes, brake and tire wear, and road dust — has been linked to increased rates ...
Doctors whose psychological needs are met is associated with greater well-being in the new digital era
2023-11-27
Canadian researchers examined how the rapid shift to using virtual care during the COVID-19 pandemic has impacted primary care doctors’ well-being at work. They utilized a self-determination theory (SDT) lens to examine how autonomous (vs. controlled) motivation among family physicians impacted their well-being when shifting to virtual care, and whether satisfaction (vs. frustration) of their basic psychological needs at work mediated that relationship. The researchers gathered qualitative data by surveying 156 family physicians ...
Dutch researchers explore patient profiles of those who choose to stop eating and drinking to hasten death
2023-11-27
Some patients choose to voluntarily stop eating and drinking (VSED) as a way of hastening death. Researchers from the Amsterdam University Medical Centre conducted a study to describe patients’ motives for doing so, how they decide to voluntarily stop eating and drinking, and the way in which they prepare to do so, along with how they involve others. The researchers conducted qualitative interviews with 29 patients living in the Netherlands. Among 29 cases, 24 started VSED and 19 died. Thirteen cases were included before and ...